José A. Pérez Simón

José A. Pérez Simón

Universidad de Sevilla

H-index: 58

Europe-Spain

About José A. Pérez Simón

José A. Pérez Simón, With an exceptional h-index of 58 and a recent h-index of 33 (since 2020), a distinguished researcher at Universidad de Sevilla, specializes in the field of Trasplante Hematopoyético, Terapia Celular, Hemopatías Malignas..

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young …

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in …

Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Safety and Efficacy of Axatilimab in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A …

Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of …

José A. Pérez Simón Information

University

Position

Medicina

Citations(all)

11823

Citations(since 2020)

4373

Cited By

10204

hIndex(all)

58

hIndex(since 2020)

33

i10Index(all)

169

i10Index(since 2020)

109

Email

University Profile Page

Universidad de Sevilla

Google Scholar

View Google Scholar Profile

José A. Pérez Simón Skills & Research Interests

Trasplante Hematopoyético

Terapia Celular

Hemopatías Malignas.

Top articles of José A. Pérez Simón

Title

Journal

Author(s)

Publication Date

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young …

Frontiers in Immunology

Águeda Molinos-Quintana

Anna Alonso-Saladrigues

Blanca Herrero

Teresa Caballero-Velázquez

Víctor Galán-Gómez

...

2024/1/16

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in …

Frontiers in Immunology

Águeda Molinos-Quintana

Anna Alonso-Saladrigues

Blanca Herrero

Teresa Caballero-Velázquez

Víctor Galán-Gómez

...

2024/2/7

Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Stephen J Schuster

Nathan H Fowler

Michael Dickinson

Joaquin Martinez-Lopez

Arne Kolstad

...

2024/2/1

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Blood

Martin Dreyling

Nathan Hale Fowler

Michael Dickinson

Joaquin Martinez-Lopez

Arne Kolstad

...

2024/1/11

Safety and Efficacy of Axatilimab in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Transplantation and Cellular Therapy

Zachariah DeFilipp

Stephanie J Lee

Iskra Pusic

Sally Arai

José Antonio Pérez-Simón

...

2024/2/1

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations

Beatriz Guijarro-Albaladejo

Cristina Marrero-Cepeda

Eduardo Rodríguez-Arbolí

Belén Sierro-Martínez

José Antonio Pérez-Simón

...

2024/4/17

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A …

Transplantation and cellular therapy

Tania Jain

Hua-Ling Tsai

Amy E DeZern

Lukasz P Gondek

Hany Elmariah

...

2022/5/1

Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of …

Bone Marrow Transplantation

Marie Robin

Simona Iacobelli

Linda Koster

Jakob Passweg

Daniele Avenoso

...

2024/3/15

Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens.

Pediatric Blood & Cancer

Salvador Payán-Pernía

José Antonio Pérez-Simón

José Antonio García-Erce

2024/1/22

Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists

Climacteric

MÁ Martínez-Maestre

C Castelo-Branco

AM Calderón

I Espigado

JA Pérez-Simón

...

2024/2/27

Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation

Annals of Hematology

María Louzao

María Teresa Vargas

Emma Meseguer

Begoña Pedrote Amador

Jose Antonio Perez Simón

...

2023/11

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Blood

Lucia Lopez Corral

Cristina Blázquez Goñi

Estefanía Pérez López

Francisco Manuel Martín Domínguez

Almudena Cabero Martínez

...

2023/11/28

Female Sex Effect on Anti-CD19 CART Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Grupo Español De Trasplante y Terapia Celular (GETH-TC) Study

Blood

Nicole Fabbri

Marta Peña

Pere Barba

Gloria Iacoboni

Mi Kwon

...

2023/11/28

Prognostic value of measurable residual disease in patients with AML undergoing HSCT: a multicenter study

Blood

Lok Lam Ngai

Coen R Veenstra

Patrycja Gradowska

Angèle Kelder

Willemijn Scholten

...

2023/11/2

Supplementary Material: Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

Clara B García-Calderón

Belén Sierro-Martínez

Estefanía García-Guerrero

Luzalba Sanoja-Flores

Raquel Muñoz García

...

2023/4/14

Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA Registry

Cancers

Claudia Sargas

Rosa Ayala

María José Larráyoz

María Carmen Chillón

Estrella Carrillo-Cruz

...

2023/1/10

P1264: A PREDEFINED STRATEGY AIMED TO REDUCE ANTIBIOTIC EXPOSURE OF SCT RECIPIENTS PRESERVES DIVERSITY AND COMPOSITION OF INTESTINAL MICROBIOTA AND REDUCES THE INCIDENCE OF …

HemaSphere

Ildefonso Espigado

Nancy Rodríguez-Torres

Silvia Jimenez-Jorge

Lucrecia Yáñez Sansegundo

Lourdes Vázquez López

...

2023/8/1

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid …

Bone marrow transplantation

Jaime Sanz

Myriam Labopin

Thomas Pabst

Jurjen Versluis

Gwendolyn Van Gorkom

...

2023/11

Preliminary Results of Nathali-01: A First-in-Human Phase I/IIa Study of UCART20x22, a Dual Allogeneic CAR-T Cell Product Targeting CD20 and CD22, in Relapsed or Refractory (R …

Blood

Jeremy S Abramson

Aravind Ramakrishnan

Ana Alfonso Pierola

Ira Braunschweig

Guillaume Cartron

...

2023/11/28

New Optimized Academic Anti-BCMA CAR (CARTemis-1): How Does the Manufacturing Process Impact CAR-T Cell Features?

Blood

Belén Sierro-Martínez

Virginia Escamilla Gomez

Laura Perez-Ortega

Beatriz Guijarro-Albaladejo

Paola Hernández-Díaz

...

2023/11/28

See List of Professors in José A. Pérez Simón University(Universidad de Sevilla)

Co-Authors

H-index: 91
Felipe Prosper

Felipe Prosper

Universidad de Navarra

H-index: 34
Ildefonso Espigado

Ildefonso Espigado

Universidad de Sevilla

academic-engine